Literature DB >> 31994702

Semi-automated prediction approach of target shifts using machine learning with anatomical features between planning and pretreatment CT images in prostate radiotherapy.

Yudai Kai1,2, Hidetaka Arimura3, Kenta Ninomiya1, Tetsuo Saito4, Yoshinobu Shimohigashi2, Akiko Kuraoka2, Masato Maruyama2, Ryo Toya4, Natsuo Oya4.   

Abstract

The goal of this study was to develop a semi-automated prediction approach of target shifts using machine learning architecture (MLA) with anatomical features for prostate radiotherapy. Our hypothesis was that anatomical features between planning computed tomography (pCT) and pretreatment cone-beam computed tomography (CBCT) images could be used to predict the target, i.e. clinical target volume (CTV) shifts, with small errors. The pCT and daily CBCT images of 20 patients with prostate cancer were selected. The first 10 patients were employed for the development, and the second 10 patients for a validation test. The CTV position errors between the pCT and CBCT images were determined as reference CTV shifts (teacher data) after an automated bone-based registration. The anatomical features associated with rectum, bladder and prostate were calculated from the pCT and CBCT images. The features were fed as the input with the teacher data into five MLAs, i.e. three types of artificial neural networks, support vector regression (SVR) and random forests. Since the CTV shifts along the left-right direction were negligible, the MLAs were developed along the superior-inferior and anterior-posterior directions. The proposed framework was evaluated from the residual errors between the reference and predicted CTV shifts. In the validation test, the mean residual error with its standard deviation was 1.01 ± 1.09 mm in SVR using only one feature (one click), which was associated with positional difference of the upper rectal wall. The results suggested that MLAs with anatomical features could be useful in prediction of CTV shifts for prostate radiotherapy.
© The Author(s) 2020. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

Entities:  

Keywords:  anatomical features; cone beam computed tomography; machine learning; prostate radiotherapy; target shifts

Mesh:

Year:  2020        PMID: 31994702      PMCID: PMC7246080          DOI: 10.1093/jrr/rrz105

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  21 in total

1.  Prostate positioning using cone-beam computer tomography based on manual soft-tissue registration: interobserver agreement between radiation oncologists and therapists.

Authors:  B A Jereczek-Fossa; C Pobbiati; L Santoro; C Fodor; P Fanti; S Vigorito; G Baroni; D Zerini; O De Cobelli; R Orecchia
Journal:  Strahlenther Onkol       Date:  2013-08-17       Impact factor: 3.621

2.  Feasibility of anatomical feature points for the estimation of prostate locations in the Bayesian delineation frameworks for prostate cancer radiotherapy.

Authors:  Kenta Ninomiya; Hidetaka Arimura; Motoki Sasahara; Yudai Kai; Taka-Aki Hirose; Saiji Ohga
Journal:  Radiol Phys Technol       Date:  2018-09-28

3.  Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.

Authors:  M J Zelefsky; D Crean; G S Mageras; O Lyass; L Happersett; C C Ling; S A Leibel; Z Fuks; S Bull; H M Kooy; M van Herk; G J Kutcher
Journal:  Radiother Oncol       Date:  1999-02       Impact factor: 6.280

4.  Cone-beam computed tomographic image guidance for lung cancer radiation therapy.

Authors:  Jean-Pierre Bissonnette; Thomas G Purdie; Jane A Higgins; Winnie Li; Andrea Bezjak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-25       Impact factor: 7.038

5.  Influence of volumes of prostate, rectum, and bladder on treatment planning CT on interfraction prostate shifts during ultrasound image-guided IMRT.

Authors:  Nandanuri M S Reddy; Dattatreyudu Nori; William Sartin; Samuel Maiorano; Jennifer Modena; Andrej Mazur; Adrian Osian; Brijmohan Sood; Akkamma Ravi; Seshadri Sampath; Christopher S Lange
Journal:  Med Phys       Date:  2009-12       Impact factor: 4.071

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Feasibility study of automated framework for estimating lung tumor locations for target-based patient positioning in stereotactic body radiotherapy.

Authors:  Satoshi Yoshidome; Hidetaka Arimura; Katsumasa Nakamura; Yoshiyuki Shioyama; Kazushige Atsumi; Yasuhiko Nakamura; Hideki Yoshikawa; Kei Nishikawa; Hideki Hirata
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

8.  Superiority of a soft tissue-based setup using cone-beam computed tomography over a bony structure-based setup in intensity-modulated radiotherapy for prostate cancer.

Authors:  Hiraku Sato; Eisuke Abe; Satoru Utsunomiya; Motoki Kaidu; Nobuko Yamana; Kensuke Tanaka; Atsushi Ohta; Mika Obinata; Junyang Liu; Gen Kawaguchi; Katsuya Maruyama; Fumio Ayukawa; Hidefumi Aoyama
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

9.  Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation.

Authors:  David Pearson; Sukhdeep K Gill; Nina Campbell; Krishna Reddy
Journal:  J Appl Clin Med Phys       Date:  2016-11-08       Impact factor: 2.102

10.  Computer-assisted framework for machine-learning-based delineation of GTV regions on datasets of planning CT and PET/CT images.

Authors:  Koujiro Ikushima; Hidetaka Arimura; Ze Jin; Hidetake Yabu-Uchi; Jumpei Kuwazuru; Yoshiyuki Shioyama; Tomonari Sasaki; Hiroshi Honda; Masayuki Sasaki
Journal:  J Radiat Res       Date:  2016-09-08       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.